加载中
NASDAQHealthcareBiotechnology
最新数据
US$155.65
−US$11.32 · -6.78%
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
前收盘价
US$155.65
−US$11.32 · -6.78%
盘前
US$148.46
−US$7.19 · -4.62%
10月8日 8:21 ET
盘中时间采用ET。市场数据可能有所延迟。
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
日内区间
当前US$155.65
52周区间
当前US$155.65
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
62
低估
情绪
45
多空交织
风险
55
风险偏高
动量
70
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
日内区间
当前US$155.65
52周区间
当前US$155.65
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$145.2
下跌空间 6.71%报告持有此股票敞口的交易所交易基金。
ARK Innovation ETFARKK3.82亿3.45%55.62亿 USD0.75%US$88.30-2.42%
iShares Russell 2000 ETFIWM2.89亿0.37%785.63亿 USD0.19%US$277.7-1.29%
Vanguard Morningstar Total Stock Market ETFVTI2.77亿0.01%2.3万亿 USD0.03%US$381.03-0.40%
State Street SPDR S&P Biotech ETFXBI2.06亿2.00%100.75亿 USD0.35%US$150.23-0.44%
Vanguard Morningstar Small-Cap ETFVB2亿0.11%1853亿 USD0.03%US$286.98-1.41%
ARK Genomic Revolution ETFARKG1.83亿8.65%15.57亿 USD0.75%US$50.14-3.11%
Vanguard Morningstar Small-Cap Growth ETFVBK1.15亿0.25%447亿 USD0.05%US$342.24-1.50%
Vanguard Extended Market ETFVXF1.06亿0.11%954亿 USD0.05%US$233.49-1.56%ARK Innovation ETFARKKiShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIState Street SPDR S&P Biotech ETFXBIVanguard Morningstar Small-Cap ETFVBARK Genomic Revolution ETFARKGVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
